The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Pigou, A. C. (2009) · Medical Entomology and Zoology · Cited by 751
Herd immunity and herd effect: new insights and definitions
John, T. J., & Samuel, R. (2000) · European Journal of Epidemiology · doi:10.1023/a:1007626510002 · Cited by 367
Bloom, D. E., Canning, D., & Weston, M. (2017) · Fighting the Diseases of Poverty · doi:10.4324/9780203791950-8 · Cited by 238
Eradication versus control for poliomyelitis: an economic analysis
Thompson, K. M., & Tebbens, R. J. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60532-7 · Cited by 200
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
Goldie, S. J., O'Shea, M., Campos, N. G., Diaz, M., Sweet, S., & Kim, S.-Y. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.053 · Cited by 197
The value of vaccination: a global perspective
EHRETH, J. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00377-3 · Cited by 189
Cost-effectiveness of HPV 16, 18 vaccination in Brazil
Goldie, S. J., Kim, J. J., Kobus, K., Goldhaber-Fiebert, J. D., Salomon, J., O'Shea, M. K. H., Xavier Bosch, F., de Sanjosé, S., & Franco, E. L. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.058 · Cited by 167
Cost effectiveness analysis of strategies for child health in developing countries
Tan-Torres Edejer, T., Aikins, M., Black, R., Wolfson, L., Hutubessy, R., & Evans, D. B. (2005) · BMJ · doi:10.1136/bmj.38652.550278.7c · Cited by 165
Economic analysis of the global polio eradication initiative
Tebbens, R. J. D., Pallansch, M. A., Cochi, S. L., Wassilak, S. G. F., Linkins, J., Sutter, R. W., Aylward, R. B., & Thompson, K. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.026 · Cited by 149
Sinha, A., Levine, O. S., Knoll, M. D., Muhib, F., & Lieu, T. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60195-0 · Cited by 147
Self-citationHealth and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
Diaz, M., Kim, J. J., Albero, G., de Sanjosé, S., Clifford, G., Bosch, F. X., & Goldie, S. J. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604462 · Cited by 142 · cited 1×
“2 for our search strategy) [10–117].”
Fischer, T. K., Anh, Đ. Đ., Antil, L., CAT, N. D., Kilgore, P. E., Thiểm, V. Đ., Rheingans, R., Tho, L. H., Glass, R. I., & Bresee, J. (2005) · The Journal of Infectious Diseases · doi:10.1086/497339 · Cited by 130
Bloom, D. E., Canning, D., & Jamison, D. T. T. (2004) · doi:10.5089/9781451953411.022.a006 · Cited by 130
Bärnighausen, T., Bloom, D. E., Canning, D., Friedman, A. S., Levine, O. S., O’Brien, J., Privor-Dumm, L. A., & Walker, D. G. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.090 · Cited by 129
Self-citationBerndt, E. R., Glennerster, R., Kremer, M. R., Lee, J., Levine, R., Weizsäcker, G., & Williams, H. (2006) · Health Economics · doi:10.1002/hec.1176 · Cited by 120
Projected Cost‐Effectiveness of Rotavirus Vaccination for Children in Asia
Podewils, L. J., Antil, L., Hummelman, E., Bresee, J., Parashar, U. D., & Rheingans, R. (2005) · The Journal of Infectious Diseases · doi:10.1086/431513 · Cited by 117
The effect of vaccination on children's physical and cognitive development in the Philippines
Bloom, D. E., Canning, D., & Shenoy, E. S. (2011) · Applied Economics · doi:10.1080/00036846.2011.566203 · Cited by 112
Insinga, R. P., Dasbach, E. J., Elbasha, E. H., Puig, A., & Reynales-Shigematsu, L. M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.10.056 · Cited by 104
The cost of influenza in Thailand
Simmerman, J. M., Lertiendumrong, J., Dowell, S. F., Uyeki, T. M., Olsen, S. J., Chittaganpitch, M., Chunsutthiwat, S., & Tangcharoensathien, V. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.12.060 · Cited by 95
Tate, J. E., Rheingans, R., O’Reilly, C. E., Obonyo, B., Burton, D. C., Tornheim, J. A., Adazu, K., Jaron, P., Ochieng, J. B., Kerin, T., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605058 · Cited by 94
(2005) · doi:10.5040/9798400684463.ch-007 · Cited by 85
Goldie, S. J., O'Shea, M. K. H., Díaz, M., & Kim, S. (2008) · Reproductive Health Matters · doi:10.1016/s0968-8080(08)32409-4 · Cited by 82
Stack, M. L., Ozawa, S., Bishai, D. M., Mirelman, A. J., Tam, Y., Niessen, L. W., Walker, D. G., & Levine, O. S. (2011) · Health Affairs · doi:10.1377/hlthaff.2011.0382 · Cited by 82
Self-citationRotavirus Vaccination: Cost‐Effectiveness and Impact on Child Mortality in Developing Countries
Atherly, D., Dreibelbis, R., Parashar, U. D., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605033 · Cited by 82
Aggarwal, R., Ghoshal, U. C., & Naik, S. R. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00382-3 · Cited by 82
Cook, J., Jeuland, M., Whittington, D., Poulos, C. M., Clemens, J. D., Sur, D., Anh, Đ. Đ., Agtini, M. D., & Bhutta, Z. A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.040 · Cited by 79
Hutton, D. W., So, S. K., & Brandeau, M. L. (2009) · Hepatology · doi:10.1002/hep.23310 · Cited by 78
Sinha, A., Clemens, J. D., Acosta, C. J., Kumar, R., Bahl, R., Poulos, C. M., Sazawal, S., Bhan, M. K., Mahalanabis, D., & Whittington, D. (2021) · PubMed · doi:10.17615/jd2f-p485 · Cited by 78
The demand for a dengue vaccine: A contingent valuation survey in Metro Manila
Palanca-Tan, R. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.011 · Cited by 76
Aballéa, S., Chancellor, J. V. M., Martin, M., Wutzler, P., Carrat, F., Gasparini, R., Toniolo-Neto, J., Drummond, M., & Weinstein, M. C. (2007) · Value in Health · doi:10.1111/j.1524-4733.2006.00157.x · Cited by 74
Economic evaluation of pneumococcal conjugate vaccination in The Gambia
Kim, S., Lee, G. T., & Goldie, S. J. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-260 · Cited by 72
Ozawa, S., Stack, M. L., Bishai, D. M., Mirelman, A. J., Friberg, I. K., Niessen, L. W., Walker, D. G., & Levine, O. S. (2011) · Health Affairs · doi:10.1377/hlthaff.2011.0381 · Cited by 63
Self-citationKim, J. J., Kobus, K. E., Díaz, M., O'Shea, M. K. H., Minh, H. V., & Goldie, S. J. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.038 · Cited by 62
Akumu, A. O., English, M., Scott, J. A. G., & Griffiths, U. K. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.034686 · Cited by 61
Sinanovic, E., Moodley, J., Barone, M. A., Mall, S., Cleary, S., & Harries, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.004 · Cited by 61
Kim, S., Salomon, J. A., & Goldie, S. J. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.038893 · Cited by 61
Jeuland, M., Lucas, M. E. S., Clemens, J. D., & Whittington, D. (2009) · Journal of Development Economics · doi:10.1016/j.jdeveco.2009.06.007 · Cited by 59
Health and economic impact of rotavirus vaccination in GAVI-eligible countries
Kim, S., Sweet, S., Slichter, D., & Goldie, S. J. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-253 · Cited by 58
Cost-effectiveness of universal childhood hepatitis A vaccination in Chile
Valenzuela, M. T., Jacobs, R. J., Arteaga, Ó., Navarrete, M. S., Meyerhoff, A. S., & Innis, B. L. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.03.021 · Cited by 57
Rose, J., Hawthorn, R. L., Watts, B., & Singer, M. E. (2009) · BMJ · doi:10.1136/bmj.b3653 · Cited by 57
The cost of treatment for child pneumonias and meningitis in the Northern Areas of Pakistan
Hussain, H., Waters, H., Omer, S. B., Khan, A. J., Baig, I. Y., Mistry, R. F., & Halsey, N. A. (2006) · The International Journal of Health Planning and Management · doi:10.1002/hpm.847 · Cited by 56
Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients.
Wongsurakiat, P., Lertakyamanee, J., Maranetra, K. N., Jongriratanakul, S., & Sangkaew, S. (2003) · PubMed · Cited by 55
Economic evaluation of a routine rotavirus vaccination programme in Indonesia
Wilopo, S. A., Kilgore, P. E., Kosen, S., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.040 · Cited by 54
Sinha, A., Constenla, D. O., Valencia, J. E., O’Loughlin, R. E., Gomez, E., de la Hoz, F., Valenzuela, M. T., & de Quadrós, C. A. (2008) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892008001100002 · Cited by 54
Ehrenkranz, P. D., Lanata, C. F., Penny, M. E., et al. (2001) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892001001000004 · Cited by 54
Cost–benefit comparisons of investments in improved water supply and cholera vaccination programs
Jeuland, M., & Whittington, D. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.02.104 · Cited by 49
Cost-effectiveness analysis of routine rotavirus vaccination in Brazil
de Soárez, P. C., Valentim, J., Sartori, A. M. C., & Novaes, H. M. D. (2008) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892008000400001 · Cited by 46
Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted
Ellis, A., Rüttimann, R. W., Jacobs, R. J., Meyerhoff, A. S., & Innis, B. L. (2007) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892007000500002 · Cited by 45
Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries
Colantonio, L. D., Gomez, J. A., Demarteau, N., Standaert, B. A., Pichón-Rivière, A., & Augustovski, F. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.097 · Cited by 44
Bawah, A. A., Phillips, J. F., Adjuik, M., Vaughan-Smith, M., MacLeod, B., & Binka, F. N. (2009) · Scandinavian Journal of Public Health · doi:10.1177/1403494809352532 · Cited by 44
Using private demand studies to calculate socially optimal vaccine subsidies in developing countries
Cook, J., Jeuland, M., Maskery, B. A., Lauria, D. T., Sur, D., Clemens, J. D., & Whittington, D. (2008) · Journal of Policy Analysis and Management · doi:10.1002/pam.20401 · Cited by 43
Gessner, B. D., Sedyaningsih, E. R., Griffiths, U. K., Sutanto, A., Linehan, M., Mercer, D., Mulholland, E. K., Walker, D. G., Steinhoff, M. C., & Nadjib, M. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318165f1ba · Cited by 42
Self-citationA cost-effectiveness analysis of universal childhood hepatitis A vaccination in China
Zhuang, G., Pan, X., & Wang, X. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.086 · Cited by 41
Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis
Acharya, A. K. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00296-7 · Cited by 41
Accounting for the full benefits of childhood vaccination in South Africa.
Bärnighausen, T., Bloom, D. E., Canning, D., & O’Brien, J. (2008) · PubMed · Cited by 40
Cost-Effectiveness Analysis of a Quadrivalent Human Papilloma Virus Vaccine in Mexico
Reynales-Shigematsu, L. M., Rodrigues, E. R., & Lazcano-Ponce, E. C. (2009) · Archives of Medical Research · doi:10.1016/j.arcmed.2009.08.004 · Cited by 40
Potential Cost‐Effectiveness of a Rotavirus Immunization Program in Rural China
Wang, X., Riewpaiboon, A., von Seidlein, L., Xing-bao, C., Kilgore, P. E., Ma, J., Qi, S., Zhang, Z., Hao, Z.-Y., Chen, J., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605632 · Cited by 39
Tediosi, F., Hutton, G., Maire, N., Smith, T. A., Ross, A. J., & Tanner, M. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.75.131 · Cited by 39
Willingness to pay for hypothetical malaria vaccines in rural Burkina Faso
Sauerborn, R., Gbangou, A., Dong, H., Przyborski, J. M., & Lanzer, M. (2005) · Scandinavian Journal of Public Health · doi:10.1080/14034940510005743 · Cited by 38
Willingness to pay for three hypothetical malaria vaccines in Nigeria
Udezi, W., Usifoh, C. O., & Ihimekpen, O. O. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.07.018 · Cited by 35
Chan, P., & Abdellatif, M. (2003) · Acta Paediatrica · doi:10.1111/j.1651-2227.2003.tb00582.x · Cited by 32
Amirfar, S., Hollenberg, J. P., & Karim, S. S. A. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000230526.79341.83 · Cited by 31
du Châtelet, I. P., Gessner, B. D., & Silva, A. D. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00066-4 · Cited by 30
Broughton, E. I. (2007) · Journal of Public Health · doi:10.1093/pubmed/fdm055 · Cited by 29
Cost-effectiveness of HPV vaccination in the prevention of cervical cancer in Malaysia.
Ezat, W. P. S., & Aljunid, S. M. (2010) · PubMed · Cited by 28
Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina
Giglio, N., Cane, A. D., Micone, P., & de Gentile, A. S. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.12.070 · Cited by 25
The societal value of vaccination in developing countries
Shearley, A. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00303-5 · Cited by 24
Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation
Platonov, A. E., Griffiths, U. K., Voeykova, M. V., Platonova, O. V., Шаханина, И. Л., Чистякова, Г. Г., & Robertson, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.11.054 · Cited by 22
Low-cost interventions accelerate epidemiological transition in Upper East Ghana
Meij, H. J., de Craen, A. J. M., Agana, J., et al. (2008) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2008.09.015 · Cited by 18
Cited by
Increasing Vaccination: Putting Psychological Science Into Action
Brewer, N. T., Chapman, G. B., Rothman, A. J., Leask, J., & Kempe, A. (2017) · Psychological Science in the Public Interest · doi:10.1177/1529100618760521 · Cited by 1,233
Bhutta, Z. A., Das, J. K., Walker, N., Rizvi, A., Campbell, H., Rudan, I., & Black, R. E. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60648-0 · Cited by 675
Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011–20
Ozawa, S., Clark, S., Portnoy, A., Grewal, S., Brenzel, L., & Walker, D. G. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1086 · Cited by 371
Self-citationAbbas, K., Procter, S. R., van Zandvoort, K., Clark, A., Funk, S., Mengistu, T., Hogan, D., Dansereau, E., Jit, M., Flasche, S., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30308-9 · Cited by 362
Li, X., Mukandavire, C., Cucunubá, Z. M., Echeverria Londono, S., Abbas, K., Clapham, H. E., Jit, M., Johnson, H. L., Papadopoulos, T., Vynnycky, E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32657-x · Cited by 300
Metadata
- Authors
- Ozawa, S., Mirelman, A., Stack, M. L., Walker, D. G., & Levine, O. S.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 31
- Issue
- 1
- Pages
- 96-108
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2079994303
- Cited by
- 254
- References
- 72
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.